EPISODE · Jun 1, 2025 · 39 MIN
#132 | What It Really Takes To Bring a Biotech Platform To Market
Great science doesn’t guarantee commercial success - especially in biotech.In this episode, Hakeem sits down with Nigel Theobald, founder and CEO of N4 Pharma, to unpack what it really takes to turn an RNA delivery platform into a viable, scalable business. From investor pressure to team building and tough pivots, Nigel shares lessons every biotech or MedTech founder needs to hear.Here’s what you’ll learn: – How to go from a biotech platform to a commercial product – What it takes to build a virtual, world-class team in a capital-intensive space – How to stay resilient when timelines shift and strategies evolveIf you're building something at the edge of science and business - this episode is for you.
Embed this episode
What this episode covers
What does it really take to bring a biotech product to market? Nigel Theobald, founder and CEO of N4 Pharma, joins me to share the real highs and lows of turning science into a scalable business. We dive into: The challenges of RNA drug delivery How to stay resilient when plans change Building a virtual, world-class team The path from platform to product This is a must-listen for anyone in biotech, medtech, or startup life. 📺 Watch on Youtube:https://youtu.be/Jy1JA5J1-F8 📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes (https://thesalesaccelerationformula.com/podcast-show-notes)
NOW PLAYING
#132 | What It Really Takes To Bring a Biotech Platform To Market
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.